Troutman Pepper advised Apnimed on the deal.Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders,…
Apnimed’s Series C Financing


Troutman Pepper advised Apnimed on the deal.Apnimed, a clinical-stage pharmaceutical company focused on developing oral pharmacologic treatments to address obstructive sleep apnea (OSA) and related disorders,…
…